What is Qwoted?

Qwoted is a free expert network: we help reporters connect with experts & we help those same experts build relationships with top reporters.

Event Date Mon May 24 EDT - Tue May 25 EDT (over 1 year ago)
Location Online
Region All

Pharmaceutical pricing has always been a focus of lawmakers of the federal and state levels alike. With the recent multitude of executive orders and an increase in calls for pricing transparency from all levels of government, navigating this space has become more complicated than ever before. With this in mind, DGE’s Rx Pricing and Reimbursement conference has been developed to provide an in-depth look at the issues facing the industry today. Join us on our fully interactive platform as a faculty of industry leaders provide you with the information needed for submitting successful FSS proposals and adapting methodologies to remaining compliant with ever-changing government regulations.

Topics covered will include:
• Discuss the Latest Pricing Challenges Surrounding the 340B Program
• Explore the Changes to Rebates and Safe Harbor Effecting Medicare Part D
• Analyze Newly Developed Federal Pricing Transparency Laws in Public Payor Programs
• Analyze the Final Rule on the Importation of Pharmaceuticals
• Discuss the Recent Development of the “Most Favorite Nations” Rule

Top Reasons to Attend:
• An in-depth look at the current status of the proposed 340B contract pharmacy rule
• Discussion on the IPI in relation to Medicaid pricing
• Thorough review of th increase in state regulations and the call for pricing transparency
• Strategies to navigate the verticalization of the pharmaceutical pricing industry

Who Should Attend:
• Market Access
• Government Pricing
• Compliance
• Ethics
• Legal Affairs
• Transparency Reporting
• Aggrigate Spending
• Auditing
• Monitoring
• Investigations
• Training
• Oversight
• Risk Management
• Patient Support


2021 Speakers

Amie Phillips Pablo
Director, Novo Nordisk

Donna White
Cive President Compliance, Chiesi

Greg Madden
Managing Member, Orlaithe Consulting LLC

Gregg Shapiro
Chief, Affirmative Civil Enforcement Unit United States Attorney’s Office, District of Massachusetts

James Kim
Partner, McDermott Will & Emery LLP

Jim Stansel
General Counsel, PhRMA

John Murphy III
Vice President, Assistant General Counsel, Biotechnology Innovation Organization

Judy Waltz
Partner, Foley & Lardner LLP

Keren Tenenbaum
VP Assistant General Counsel, Head of Legal, SALIX

Mallory O’Connor
Executive Director, Public Policy, Mallinckrodt Pharmaceuticals

Michael Grivnovics
Director, Veterans Affairs Office of the Inspector General

Nicholas Uehlecke
Former Senior Advisor, U.S. Department of Health and Human Services

Robert Hill
Partner, Reed Smith LLP

Rodney Emerson
Executive Director, Novartis Sandoz

Shraddha Eswaran
Government Pricing Analyst, Lupin Pharmaceuticals

Stephanie Trunk
Partner, Arent Fox LLP

Trevor Wear
Partner, Sidley Austin LLP

Sponsors & Partners

2021 Sponsors & Partners

• PM 360
• Scarrit Group Inc.
• H1
• Invivo
• MedThink SciCom
• 81 QD
• Within 3
• Medispend
• FDA NewsWatch
• VOXX Analytics
• MEDTube

• PM360
• MEDTube
• Scaritt Group Inc.